US Revokes Visas for Indian Executives over Fentanyl Allegations

The US has revoked and denied visas for certain Indian business leaders allegedly involved in fentanyl precursor trafficking. Although identities remain undisclosed, this marks a significant step in the US's efforts against synthetic narcotic trafficking. The US embassy emphasized collaboration with India to confront this shared drug threat.


Devdiscourse News Desk | New Delhi | Updated: 18-09-2025 18:26 IST | Created: 18-09-2025 18:26 IST
US Revokes Visas for Indian Executives over Fentanyl Allegations
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • India

The United States has taken a strong stance against illegal drug trafficking by revoking visas of Indian business executives suspected of involvement in fentanyl precursor trafficking. This action, announced on Thursday, aligns with the Trump administration's broader efforts to curb synthetic narcotic flow into the country.

While the identities of the affected individuals remain undisclosed, US Charge d'Affaires Jorgan Andrews emphasized the consequential measures against entities engaged in illegal drug production and trafficking. The embassy's move highlights the ongoing collaboration with India to address transnational threats.

The US embassy in New Delhi reaffirmed its commitment to combating this critical issue, further scrutinizing visa applicants linked to companies suspected of trafficking fentanyl precursors. It cited sections of the US Immigration and Nationality Act as the legal basis for these punitive actions, underscoring the seriousness of the initiative.

Give Feedback